Monovisc 690-016
Monovisc 690-016 is a synovial fluid supplementation medium (FDA Class III; FDA product code MOZ, Acid, Hyaluronic, Intraarticular) made by Anika Therapeutics, Inc., approved under FDA PMA P090031 on 25 Feb 2014 and listed in FDA GUDID since 31 May 2017 (UDI-DI 10886705025183), active as of 23 Oct 2026.
Active
PMA
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number10886705025183 | Date31 May 2017 | StatusListed |
| United States | FDA PMAAPPR | NumberP090031 | Date25 Feb 2014 | StatusActive |
Official records
- AccessGUDID record 10886705025183
- FDA PMA database P090031
From the FDA record
- Device description
- 4 mL, 22 mg/mL High Molecular Weight Hyaluronan
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA PMA P090031 decided 25 Feb 2014 Active
- FDA GUDID UDI-DI 10886705025183 listed 31 May 2017 Listed
Timeline
- Approved FDA PMA P090031
- Listed FDA GUDID 10886705025183
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade name
- Monovisc
- Generic name
- Synovial fluid supplementation medium
- Model / reference
- 690-016
- Primary DI / UDI-DI
- 10886705025183
- PMA number
- FDA product code
- MOZ
- GMDN term
- Synovial fluid supplementation medium
- Device class
- Class III
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code MOZ (Acid, Hyaluronic, Intraarticular).
- TriVisc by Channel-Markers Medical, LLC
- Synvisc Hylan G-F 20 by Sanofi Genzyme Corp.
- TRILURON by Fidia Farmaceutici S.p.A.
- Supartz by Seikagaku Corp.
- Gel-One by Seikagaku Corp.
- GenVisc 850 by Channel-Markers Medical, LLC
- Hymovis High Molecular Weight Viscoelastic Hyaluronan by Fidia Farmaceutici
- Hyalgan Acid, Hyaluronic, Intraarticular by Fidia Farmaceutici S.p.A.
- Euflexxa (1% Sodium Hyaluronate) by Ferring Pharmaceuticals, Inc.
- Durolane by BIOVENTUS LLC